Compare IMRX & BLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMRX | BLND |
|---|---|---|
| Founded | 2008 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.3M | 264.9M |
| IPO Year | 2021 | 2021 |
| Metric | IMRX | BLND |
|---|---|---|
| Price | $3.83 | $1.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $17.00 | $2.19 |
| AVG Volume (30 Days) | 752.9K | ★ 1.6M |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 37.75 | ★ 58.33 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $123,585,000.00 |
| Revenue This Year | N/A | $2.77 |
| Revenue Next Year | N/A | $10.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.35 | $0.85 |
| 52 Week High | $8.48 | $3.44 |
| Indicator | IMRX | BLND |
|---|---|---|
| Relative Strength Index (RSI) | 49.87 | 44.96 |
| Support Level | $3.38 | $0.88 |
| Resistance Level | $4.16 | $1.63 |
| Average True Range (ATR) | 0.25 | 0.10 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 56.52 | 39.49 |
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segment is Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience. The key revenue for the company is generated from the Blend Platform segment. Company has it's assets in united states, India and Mexico regions.